Zhao, B., Zhou, Y., Cheng, N., Zheng, X., Chen, G., Qi, X., . . . Zeng, Y. Targeted inhibition of PDGFRA with avapritinib, markedly enhances lenvatinib efficacy in hepatocellular carcinoma in vitro and in vivo: Clinical implications. BMC.
Chicago Style (17th ed.) CitationZhao, Bixing, et al. Targeted Inhibition of PDGFRA with Avapritinib, Markedly Enhances Lenvatinib Efficacy in Hepatocellular Carcinoma in Vitro and in Vivo: Clinical Implications. BMC.
MLA (9th ed.) CitationZhao, Bixing, et al. Targeted Inhibition of PDGFRA with Avapritinib, Markedly Enhances Lenvatinib Efficacy in Hepatocellular Carcinoma in Vitro and in Vivo: Clinical Implications. BMC.
Warning: These citations may not always be 100% accurate.